Advertisement

Topics

Inamori Foundation Company Profile

21:49 EST 5th December 2016 | BioPortfolio

The non-profit Inamori Foundation was established in 1984 by Dr. Kazuo Inamori, founder and chairman emeritus of Kyocera (NYSE:KYO) and KDDI Corporation. The Foundation created the Kyoto Prize in 1985, in line with Dr. Inamori’s belief that a human being has no higher calling than to strive for the greater good of society, and that the future of humanity can be assured only when there is a balance between our scientific progress and our spiritual depth. As of the 26th Kyoto Prize ceremony (November 10, 2010), the prize has been awarded to 84 individuals and one foundation — collectively representing 15 nations. Individual laureates range from scientists, engineers and researchers to philosophers, painters, architects, sculptors, musicians and film directors. The United States has produced the most recipients (34), followed by Japan (14), the United Kingdom (12), and France (8).


News Articles [630 Associated News Articles listed on BioPortfolio]

National Parkinson Foundation, Parkinson’s Disease Foundation merge

The boards of directors of the National Parkinson Foundation (NPF) and the Parkinson’s Disease Foundation (PDF) have finalized the merger of the two non-profit organizations. The organization will o...

U.S. Chamber Foundation and Robert Wood Johnson Foundation Seek Nominations to Recognize ...

WASHINGTON, DC--(Marketwired - October 20, 2016) -The U.S. Chamber of Commerce Foundation today opened the nomination process for the Health Means Business Healthy10 Read more...

Biophysics fights cancer

(National Science Foundation) Whether it focuses on determining why certain cancers develop drug resistance, finding a way to improve individual's immune systems or better understanding cancer cell ev...

#jobs #lifescience The Novo Nordisk Foundation: Novo Nordisk Foundation Young Investigator Awards

// TBD: The Novo Nordisk Foundation: YOUNG INVESTIGATOR AWARDS. International Call for Applications within the areas of biomedicine & biotechnology. Grants up to 20 million Danish kroner Denmark ...

NACDS Foundation to recognize CDC and its collaboration against Zika virus

Michael JohnsenThe NACDS Foundation has continued to advance its mission this year through several vital initiatives, including a collaborative response to the Zika virus public health emergency with ...

ASCRS Foundation to provide free cataract surgeries to eligible patients

The American Society of Cataract and Refractive Surgery Foundation announced its Operation Sight charitable initiative will provide free cataract surgery to eligible patients during National Sight Wee...

Residency Opportunity: Brocher Foundation

The Brocher Foundation is located on the shores of the Geneva Lake, in Hermance (Geneva – Switzerland). The Brocher Foundation residencies last between one and four months. They give researcher...

California Community Foundation Unveils "We Are Los Angeles" Public Art Exhibit in Honor of Foundation's Centennial

LOS ANGELES, Nov. 12, 2016 (GLOBE NEWSWIRE) -- The California Community Foundation (CCF) is celebrating the culmination of its 100th year with a public art exhibit exploring social issues in Los Ange...

Drugs and Medications [0 Results]

None

PubMed Articles [235 Associated PubMed Articles listed on BioPortfolio]

Erratum to: Serum creatine kinase isoenzymes in children with osteogenesis imperfecta.

Potential cost-effectiveness for using patient decision aids to guide osteoporosis treatment.

We use a model to predict whether using a patient decision aid in patients considering bisphosphonate therapy would be a good use of health resources. We found that if the decision aid improved adhere...

Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.

The benefits of pharmaceutical treatment for osteoporosis may be limited for a number of patients, as they continue to experience fractures. Alternative treatments may be considered for subjects whom ...

Understanding fragility fracture patients' decision-making process regarding bisphosphonate treatment.

We aimed to understand how patients 50 years and older decided to persist with or stop osteoporosis (OP) treatment. Processes related to persisting with or stopping OP treatments are complex and dyna...

Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis.

The aim of this review is to compare the efficacy and safety of denosumab over other treatments for osteoporosis. The results of this study suggest that the safety of denosumab and its efficacy in red...

Clinical Trials [39 Associated Clinical Trials listed on BioPortfolio]

Improvement of Ambulance Response Times in Karachi, Pakistan

The investigators hypothesize that spatial analysis of the location data of ambulance calls can improve prehospital care provided by Aman Foundation in Karachi, Pakistan by decreasing ambu...

VircapSeq Virus Detection in Sézary Syndrome

This study will be using this technique, called "VirCapSeq-VERT" to analyze the white blood cells of patients with Sézary syndrome. This could provide the foundation for future studies lo...

Comparing Different Methods of Patient Education on Preeclampsia

Preeclampsia is a life-threatening condition unique to pregnancy which occurs in 5-8% of all pregnancies. It contributes to a large proportion of maternal mortality worldwide and these dea...

The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients

The purpose of this study is to test the expression of microRNAs related to the syndromes after the intervention of Tongguan capsule,preliminarily to investigate the mechanism of the effec...

Improving Functions in Veterans With Post-traumatic Peripheral Neuropathic Pain

The proposed study will set the foundation for future multi-center studies. To validate tMS as a non-contact and non-invasive pain treatment option for reducing pain in Veterans with PTP-N...

Companies [1 Associated Companies listed on BioPortfolio]

Inamori Foundation

The non-profit Inamori Foundation was established in 1984 by Dr. Kazuo Inamori, founder and chairman emeritus of Kyocera (NYSE:KYO) and KDDI Corporation. The Foundation created th...

More Information about "Inamori Foundation" on BioPortfolio

We have published hundreds of Inamori Foundation news stories on BioPortfolio along with dozens of Inamori Foundation Clinical Trials and PubMed Articles about Inamori Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inamori Foundation Companies in our database. You can also find out about relevant Inamori Foundation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record